Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N-Acetyl-Dl-Valine

    • Product Name N-Acetyl-Dl-Valine
    • Alias Acetyl-DL-valine
    • Einecs 247-535-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    573671

    Chemical Name N-Acetyl-DL-Valine
    Cas Number 3849-76-1
    Molecular Formula C7H13NO3
    Molar Mass 159.18 g/mol
    Appearance White to off-white crystalline powder
    Solubility In Water Soluble
    Boiling Point Decomposes before boiling
    Melting Point 162-164°C
    Storage Temperature Room temperature
    Purity Typically ≥98%
    Iupac Name N-acetyl-2-amino-3-methylbutanoic acid
    Smiles CC(C)C[C@@H](NC(C)=O)C(=O)O
    Synonyms N-Acetylvaline; Acetyl-DL-valine

    As an accredited N-Acetyl-Dl-Valine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The 100g N-Acetyl-DL-Valine is packaged in a sealed, labeled amber glass bottle with a tamper-evident cap for safety.
    Shipping N-Acetyl-Dl-Valine is shipped in sealed, chemical-resistant containers to ensure product integrity and prevent contamination. Packages are clearly labeled according to regulatory standards. Shipping is conducted under ambient conditions, unless otherwise specified, following all safety guidelines for non-hazardous organic compounds. Appropriate documentation and material safety data sheets (MSDS) are included.
    Storage N-Acetyl-Dl-Valine should be stored in a tightly sealed container in a cool, dry, and well-ventilated area. Keep it away from incompatible substances such as strong oxidizing agents. Store at room temperature and protect from moisture, heat, and direct sunlight. Always follow standard laboratory safety protocols, including appropriate labeling and the use of personal protective equipment when handling this chemical.
    Application of N-Acetyl-Dl-Valine

    Applications of N-Acetyl-Dl-Valine in Industrial Manufacturing

    N-Acetyl-Dl-Valine is a specialty amino acid derivative serving diverse roles across advanced fine chemical sectors. Our manufacturing expertise ensures tight material specification and consistency, supporting downstream producers in regulated and technical industries. Below, we outline proven industrial application scenarios, highlighting composition considerations, compliance pathways, formulation practice, and typical finished product categories derived from industrial integration of this material.

    1. Pharmaceutical API and Intermediate Synthesis

    N-Acetyl-Dl-Valine functions as a protected amino acid input in peptide drug synthesis and as a process intermediate for select small-molecule APIs. It provides a critical building block during solid-phase peptide synthesis (SPPS) and solution-phase processes, facilitating selective deprotection and condensation steps under cGMP. Downstream manufacturers depend on our stringent lot traceability and low-level impurity profiles to support both early-stage R&D and commercial production.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for APIs
    • USP–NF General Notices & Requirements for Excipients (if used for injectable peptides)
    • EU GMP (Part II: Basic Requirements for Active Substances)
    • ICH Q3A Impurities in New Drug Substances

    Typical usage ratio

    • 1–10 mol% relative to total amino acid chain—in SPPS as a protected amino acid monomer
    • Intermediate concentrations determined per target API route; typically 0.5–2% by weight of total batch, basis laid down per route-of-synthesis protocol

    Downstream process integration

    • Integrated into coupling cycles of automated or manual peptide synthesizers during pre-resin loading or elongation steps
    • Introduced at the amidation or acylation step for small-molecule API precursors in solution-phase synthesis

    Final product types

    • Synthetic peptide drug substances (e.g., modified oligopeptides, research-grade peptides)
    • Small-molecule APIs where a stereocenter amino acid motif is specified
    • Active pharmaceutical intermediates for CDMO supply chains

    2. Medical Nutrition and Clinical Dietetic Formulations

    In medical nutrition production, N-Acetyl-Dl-Valine supports synthesis of specialized amino acid blends used in clinical feeds and metabolic disorder supplements, particularly for phenylketonuria management and low-protein diet solutions. Its controlled acetylation improves ingredient stability during spray drying, minimizing racemization and facilitating precise formulation of multi-compound nutritional mixtures. Dosing aligns with patient-specific amino acid balance targets managed under strict health authority oversight.

    Industry compliance standards

    • Codex Alimentarius Standard for Foods for Special Medical Purposes (CODEX STAN 180-1991)
    • EU Regulation (EU) No 609/2013 on Food for Specific Groups
    • US FDA 21 CFR Part 104—Nutritional Quality Guidelines for Foods
    • ISO 22000:2018 Food Safety Management Systems

    Typical usage ratio

    • 0.05–0.5% w/w of total amino acid pool—design varies by formulation specificity and patient diagnosis
    • Dose reflects both protein-replacement objectives and physiological uptake data validated in clinical settings

    Downstream process integration

    • Incorporated at dry blending or wet granulation stage before pre-mix homogenization
    • Fed directly into micronutrient dosing systems upstream of liquid fill or lyophilization modules

    Final product types

    • Medical foods for inherited metabolic disorder management
    • Parenteral nutrition solutions tailored to amino acid-restricted patients
    • Ready-to-drink clinical supplement beverages and powders

    3. Cell Culture Media and Bioprocessing Additives

    Bioprocessing manufacturers employ N-Acetyl-Dl-Valine as a non-standard amino acid source in cell culture media, supporting recombinant protein and monoclonal antibody production from CHO and HEK293 lines. The inclusion of acetylated forms optimizes amino acid bioavailability, reducing risk of metabolic imbalances compared to free amino acid feeds. Traceability and endotoxin control are essential for all raw material lots destined for biopharmaceutical upstream operations.

    Industry compliance standards

    • USP 1043 Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
    • ISO 11137 Sterilization of Healthcare Products
    • ICH Q5A Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines
    • ISO 13485:2016 for Medical Device Quality Management (where used in diagnostic reagent kits)

    Typical usage ratio

    • 10–100 mg/L final media concentration, titrated according to specific cell line metabolic demand and target protein expression yields
    • Concentration adjusted via feed optimization protocols during scale-up development

    Downstream process integration

    • Dosed into basal or feed media prior to filtration/sterilization
    • Added during fed-batch or perfusion nutrient supplementation cycles upstream of production bioreactor inoculation

    Final product types

    • Bulk cell culture media for biomanufacturing facilities
    • Therapeutic recombinant proteins and biologics
    • Diagnostic assay reagent blends incorporating advanced amino acid supplements

    4. Chiral Synthesis Auxiliary in Fine Chemical Manufacturing

    Advanced fine chemical and chiral intermediate suppliers utilize N-Acetyl-Dl-Valine as a resolving agent or auxiliary in stereoselective synthesis, including asymmetric catalysis and resolution of racemic mixtures. The acetyl group facilitates selective reactivity, enabling downstream separation of diastereomers or enhancement of target chiral center formation in small-molecule building blocks, with process engineers calibrating inputs to maximize yield and selectivity while minimizing waste.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems
    • REACH Regulation (EC 1907/2006) for chemical safety
    • cGMP guidelines where chiral intermediates supply regulated pharma or agrochemical chains
    • U.S. TSCA and SARA reporting for industrial chemical manufacturing

    Typical usage ratio

    • Stoichiometric or slight excess (1–1.2 mol equiv) relative to racemic substrate—usage defined by resolution protocol and scale
    • Sub-stoichiometric dosing possible in catalytic asymmetric synthesis approaches

    Downstream process integration

    • Introduced at the resolution step or catalytic cycle for synthesis of enantioenriched intermediates
    • Recovered or hydrolyzed post-reaction, depending on downstream isolation technology

    Final product types

    • Chiral intermediates for pharmaceutical and agrochemical building blocks
    • Non-racemic specialty chemicals for chemical research and industrial process scale-up
    • Stereochemically pure starting materials used in polymer or advanced material synthesis
    Free Quote

    Competitive N-Acetyl-Dl-Valine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N-Acetyl-Dl-Valine: Manufacturing Insight and Practical Value

    Manufacturing N-Acetyl-Dl-Valine: Our Approach

    At our facility, production of N-Acetyl-Dl-Valine stands as a direct outcome of years spent fine-tuning acetylation reactions for various amino acids. Our process starts from the careful selection of DL-Valine, an established amino acid with roles in both research and industry. Through acetylation, we modify the molecule, creating N-Acetyl-Dl-Valine with clear benefits for applications demanding this derivative.

    We invest in equipment built for consistent control of reaction parameters. The acetyl group must bond precisely, so our reactors keep temperature, pH, and mixing uniform throughout the batch. Maintaining sharp process control limits byproducts and ensures the finished compound meets the values researchers and formulators expect. This brings a repeatable product—batch after batch—tailored to sensitive downstream requirements.

    Every step inside our plant remains focused on reproducibility. We test each input, wash our systems, and use skilled operators who don’t rely on guesswork. When the batch comes through, samples go immediately to our analytical lab, where we confirm the purity with HPLC and NMR. By sticking to strict limits for impurities, we deliver N-Acetyl-Dl-Valine that integrates into both lab and industrial processes without disruption.

    Understanding the Product: Structure, Properties, and Chemical Logic

    N-Acetyl-Dl-Valine starts from the amino acid DL-Valine—a racemic mixture containing both D- and L-forms. Attaching an acetyl group to the amino function changes its chemical behavior in useful ways. Now, instead of a free amine, the molecule carries an amide. This reduces its basicity, affects solubility, and limits the types of reactions it can undergo. For researchers working in drug development or biochemistry, such changes make a clear difference in how the compound acts as an intermediate or reference standard.

    We see the finished N-Acetyl-Dl-Valine as a crystalline powder, white or close to white, with sharp melting characteristics and measurable solubility in water or alcohols. Its molecular weight, higher than DL-Valine, fits formulas where precise stoichiometry matters. Because the acetylation step uses both D- and L-forms, our product preserves the racemic mix, which most synthetic chemists and biologists prefer for these applications. Each specification—appearance, purity, solubility, melting point—results from actual batch experience. If an impurity appears, even at a fraction of a percent, our team investigates and refines the process.

    Why Acetylated Amino Acids? Real-World Applications Drive the Demand

    In practice, N-Acetyl-Dl-Valine remains a tool for those who need protection at the amino group. Chemists directly recognize its value as a building block for peptides and small molecules. Blocking the amine with an acetyl group prevents unwanted reactions in multi-step synthesis, especially where selective activation and deactivation of functional groups matter. Scientists making analogues of proteins, enzyme inhibitors, or researching metabolic pathways turn to this molecule for its stable, predictable behavior.

    Pharmaceutical development relies on derivatives such as N-Acetyl-Dl-Valine for both active drug synthesis and as analytical standards. Companies and university teams alike look for reproducible batches. The same goes for biotech, where researchers study uptake, metabolism, or modification of protected amino acids. By providing a consistent source for this compound, our production streamlines these efforts and reduces surprises in downstream results.

    In the realm of peptide chemistry, using acetylated starting materials reduces the number of steps, lowers the risk of side reactions, and improves total yield. The compound’s solubility ensures it dissolves under typical peptide coupling conditions, without requiring exotic methods. Furthermore, handling safety and environmental controls—topics often invisible to the customer—remain priorities. Our experience with waste streams, solvent recovery, and responsible disposal only deepens our commitment to producing what chemists want without cutting corners.

    Comparing N-Acetyl-Dl-Valine to Other Derivatives: What Sets It Apart?

    As a manufacturer, we interact with customers who sometimes look for alternatives—protected forms, unprotected forms, or selectively substituted derivatives. DL-Valine itself has broad uses, but N-Acetyl-Dl-Valine moves purposefully into the realm of protected intermediates. While N-Acetyl-L-Valine or N-Acetyl-D-Valine deliver single enantiomers for chiral separations, the racemic form targets researchers optimizing yields or modeling biological systems where chirality is less critical.

    Compared to Boc- or Fmoc-protected valine, our acetylated product carries a smaller, more stable protective group. Boc and Fmoc protections need special deprotection steps, sometimes involving acids or bases that add both cost and complexity. Acetyl protection, by contrast, remains robust during standard synthesis, but can often be removed under milder conditions. The product’s simplicity—both in structure and removal—means less contamination risk from byproducts or scavengers used to strip bulkier groups.

    For process chemistry teams, this translates into a cleaner workflow and fewer regulatory headaches. The acetyl group neither creates byproducts with difficult disposal requirements nor leaves behind residues that interfere with downstream processing. While some applications prioritize enantiopure material, most formulation and analytical uses of N-Acetyl-Dl-Valine benefit from the racemic mix, lower handling costs, and a minimal environmental footprint.

    Quality Control at the Source: Lessons from the Manufacturing Floor

    Early in our manufacturing journey, batches could fail specifications for reasons as simple as an imprecise pH adjustment or equipment not adequately flushed from prior products. We learned quickly that amino acid acetylation responds to subtle shifts—temperature, mixing speed, reactant purity. A single out-of-range parameter can lead to incomplete reaction or excess impurities.

    We now sample at every step, testing intermediates and adjusting process controls in real time. Our operators use checklists and process logs, not just to track materials, but as records of best practice. Once the final product appears, we run both chemical and physical property tests. HPLC confirms purity, NMR checks structure, and loss on drying reveals moisture content. Each test connects directly to what chemists and scientists downstream expect to see. If any result fails, production stops, root causes get identified, and improvement loops close before the next run.

    This boots-on-the-ground diligence directly impacts customers. Labs that require uniform performance in bioassays or formulation development can trust our batches to deliver repeatable performance. Pharmaceutical teams know their regulatory filings rest on reproducible analytical standards. Each pass through our system ends only when QC confirms every value.

    Sustainability and Regulatory Attention: Adapting to a Changing Landscape

    Manufacturing any chemical, particularly amino acid derivatives, involves a web of regulatory and environmental responsibilities. N-Acetyl-Dl-Valine’s production uses solvents and reagents covered by both safety and environmental laws. Over time, we have worked to minimize solvent use, reclaim spent materials, and prevent fugitive emissions. Plant upgrades over the last five years focused on batch containment, waste segregation, and worker training.

    We keep a close eye on updates to safety codes, workplace exposure limits, and material handling regulations. Regulatory compliance is not simply a box to tick, but a running conversation in production meetings. Labeling, shipping, and waste manifest paperwork reflect the reality of tighter oversight from authorities at every level. Any product leaving our warehouse carries documentation based on direct and traceable manufacturing inputs—a tradition rooted in both obligation and respect for customer needs.

    Customers in pharmaceuticals and food research ask pointed questions about sources, contamination history, and supplier controls. Our investments pay off most when we can show traceability from raw DL-Valine to finished acetylated product, along with evidence for each critical process checkpoint. Transparency fosters both trust and long-term partnership, a critical ingredient for any supplier working with regulated industries.

    Meeting Technical Requirements: Feedback from the Field

    The conversations we have with customers shape both our technical strategy and daily practice. Even small issues—solubility, trace metals, or odd odors—spark full reviews. If a batch presents a recurring particulate or color issue, the technical team reviews process logs and pulls retention samples. Patterns emerge not from spreadsheets, but from open dialogue and walking the production floor.

    We routinely gather feedback on performance in research, scale-up, and even pilot plant runs by our partners. Sometimes that means reformulating intermediates, modifying filtration approaches, or running additional purifications. Each request adds to our understanding of how N-Acetyl-Dl-Valine fits into real-world chemistry. Differences in performance—between our acetylated product and others—often come down to these process adjustments and the judgment built from years of chemistry done at scale.

    Reflecting this back into our production, we make continuous improvements. A drying step gets extended to reduce trace water. Solvent selection optimizes yield and crystallinity, critical for customers storing material over months. Decades of accumulated technical data flow not just into process documentation, but into instinct—recognizing the early sign of a less-than-perfect batch and making a change before anyone outside the plant ever notices.

    Common Challenges: Insights Gained from Troubleshooting

    The manufacturing of N-Acetyl-Dl-Valine never runs on autopilot. Operators watch for unexpected side reactions: incomplete acetylation, dimer formation, or unwanted color compounds. Cooling rates, agitation types, and reagent quality all factor into finished product attributes. We discovered that raw material quality—something as basic as storage conditions for DL-Valine—directly connects to downstream yield and quality.

    One persistent challenge comes from scaling reactions without losing control over impurity levels. What works at kilo lab scale can create headaches in a multi-ton batch. We respond by redesigning equipment, retuning agitation speeds, and running small test batches whenever altering scale. This practical approach—rooted in skepticism and incremental trial—results from field experience, not theory.

    Downstream, handling of mother liquors and waste remains a perennial topic. By closing loops for solvent recycling and deploying on-line monitoring of effluent, we reduce both cost and risk. Customers benefit indirectly—lowered emissions limit regulatory exposure throughout the supply chain and keep us ready for future audit scrutiny.

    Practical Advice for Users: Getting the Most from N-Acetyl-Dl-Valine

    Feedback from the labs tells us that attention to storage conditions matters. Moisture and excess heat can shift product characteristics, so sealed containers in temperature-controlled settings work best. The compound delivers maximum benefit in synthesis when handling processes mirror those used for unprotected amino acids. Our customers report that slow addition to solution, with moderate stirring, leads to the most reliable dissolution and reaction outcomes—whether for solid-phase peptide synthesis or solution-phase reactions.

    Attempts to shortcut processes—using aggressive solvents or forced heating—risk decomposition or impurity formation. Reagent compatibility checks pay dividends, especially for clients using the product in new or non-standard coupling strategies. As new synthesis methods and analytical tools emerge, we invite user feedback, both to refine our manufacturing process and help guide researchers facing new challenges.

    The Future of Manufacturing N-Acetyl-Dl-Valine: Realistic Opportunities

    The demand for N-Acetyl-Dl-Valine reflects broader trends across chemicals—a movement toward reliable supply, regulatory compliance, and continuous improvement. Our investment in automation, in-line analytics, and environmental upgrades forecast a steady future for amino acid derivatives like this one. Increasingly, customers ask about sustainability, origin, and batch-to-batch traceability. Meeting these challenges means adapting quickly, keeping open channels with process chemists and regulatory teams, and never assuming what worked last year will work tomorrow.

    Researchers pressing into novel synthetic routes push us to rethink basic chemistry, sometimes revisiting the fundamentals of acetylation or solvent use. The result: we remain rooted in established chemistry, while embracing new best practices and technologies as they emerge. This continuous engagement shapes both reliable manufacturing and the technical knowledge that underpins each kilogram of product shipped.

    Looking forward, we see N-Acetyl-Dl-Valine not as a static commodity, but as a critical building block whose production challenges demand both discipline and creativity. Staying close to both our process and our customers guarantees we deliver more than technical specifications—we deliver solutions grounded in hands-on experience.